10:31 AM ET
8-K
Capital Raise
Silexion Therapeutics Capital Raise of $840K
Silexion Therapeutics entered into an inducement agreement with warrant holders to exercise 3,216,928 existing warrants at a reduced price of $0.2603 per share. In exchange for the cash exercise, the company will issue 6,433,856 new Series F and G warrants to the holders. The transaction is expected to generate gross proceeds of approximately $0.84 million to support the company's operations.
- Value
- $840K
- Counterparty
- H.C. Wainwright & Co., LLC